Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden.

导出原文传递

翻译打印收藏纠错

第一作者： Hirosumi,Suzuki

第一单位： Division of Gastroenterology, University of Tsukuba Hospital, 2-1-1, Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.

作者： Hirosumi,Suzuki ^[1] ; Takeshi,Yamada ^[2] ; Akinori,Sugaya ^[3] ; Shunsuke,Ueyama ^[4] ; Yoshiyuki,Yamamoto ^[1] ; Toshikazu,Moriwaki ^[1] ; Ichinosuke,Hyodo ^[1]

作者单位： Division of Gastroenterology, University of Tsukuba Hospital, 2-1-1, Amakubo, Tsukuba, Ibaraki, 305-8576, Japan. ^[1] Division of Gastroenterology, University of Tsukuba Hospital, 2-1-1, Amakubo, Tsukuba, Ibaraki, 305-8576, Japan. t.yamada718@md.tsukuba.ac.jp. ^[2] Division of Gastroenterology, Ibaraki Prefectural Central Hospital, 6528, Koibuchi, Kasama, Ibaraki, Japan. ^[3] Division of Gastroenterology, Tsuchiura Kyodo Hospital, 4-1-1, Ootsuno, Tsuchiura, Ibaraki, Japan. ^[4]

关键词 Ascites Gastric cancer Nivolumab

主题词腹水(Ascites);人类(Humans);淋巴细胞计数(Lymphocyte Count);淋巴细胞(Lymphocytes);中性白细胞(Neutrophils);回顾性研究(Retrospective Studies);胃肿瘤(Stomach Neoplasms)

DOI 10.1007/s10147-020-01810-x

PMID 33090284

发布时间 2021-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交